Apple Inc. v. Vampire Labs LLC

This case, Apple Inc. v. Vampire Labs LLC, IPR2025-01215, involves an inter partes review (IPR) initiated by Apple Inc., a prominent technology operating company, against Vampire Labs LLC, a non-practicing entity (NPE) or patent assertion entity (PAE). Vampire Labs LLC, founded in Austin, Texas, in 2008, specializes in advanced power management technology aimed at eliminating "Vampire Energy Loss" and generates revenue through licensing and litigation of its intellectual property, which includes patents related to wireless power transfer technology. The IPR targeted U.S. Patent No. 8,358,103 B2, titled "AUTOMATIC COUPLING OF AN ALTERNATING CURRENT POWER SOURCE AND AN INDUCTIVE POWER APPARATUS TO CHARGE A TARGET DEVICE BATTERY." This patent generally describes an inductive battery charging method that automatically engages and disengages an inductive power apparatus and an AC power source based on a target device's battery level, specifically addressing technology for Qi-compliant wireless charging systems.

The procedural posture of this case is an IPR before the Patent Trial and Appeal Board (PTAB), a specialized administrative body within the USPTO, filed on June 27, 2025. The IPR was instituted on December 1, 2025, but was ultimately terminated as settled. This IPR was filed in response to a patent infringement lawsuit brought by Vampire Labs LLC against Apple Inc. (Case No. 1:24-cv-01377) in the Western District of Texas, presided over by Judge Alan D. Albright. The Western District of Texas is a significant venue for patent litigation due to its high volume of patent cases.

The case is notable for several reasons. It highlights the assertion pattern of NPEs like Vampire Labs, which targets major technology companies with patents relevant to widely adopted standards, such as Qi wireless charging. The IPR's termination as settled, along with the simultaneous dismissal with prejudice of the related district court infringement lawsuits against both Apple and Anker Innovations (which also involved the '103 patent), suggests a unified settlement strategy by Vampire Labs, possibly covering Apple's MagSafe ecosystem and other Qi-compliant devices. While the specific terms of the settlement were not publicly disclosed, such resolutions often involve licensing agreements, showcasing how IPRs serve as a powerful tool for defendants like Apple to challenge patent validity and achieve resolution in parallel district court disputes.

The search results provide a comprehensive picture of the IPR and its related district court litigation.

Here's a breakdown of the key information gathered:

• Parallel District Court Case: Vampire Labs, LLC v. Apple Inc., Case No. 1:24-cv-01377 (W.D. Texas). This case was filed on November 12, 2024, in the Western District of Texas and asserted US Patent No. 8,358,103 B2 (and 8,575,917 B2). Judge Alan D. Albright was assigned to the case.
• IPR Filing: Apple Inc. filed IPR2025-01215 against Vampire Labs LLC on June 27, 2025, challenging U.S. Patent No. 8,358,103.
• Related Matters in PTAB: Vampire Labs, in its Mandatory Notices to the PTAB, identified the district court case 1:24-cv-01377-ADA (WDTX) against Apple Inc. and another case 1:24-cv-01378-ADA against Anker Innovations Ltd. as related matters.
• IPR Institution Decision: The PTAB issued an institution decision on December 1, 2025. The specific outcome of the institution (whether all or some claims were instituted) is not detailed in the snippets, but the overall status is "Terminated-Settled".
• Settlement in District Court: On January 8, 2026, both Apple and Vampire Labs filed a joint stipulation of dismissal with prejudice in the district court case (1:24-cv-01377) pursuant to Federal Rule of Civil Procedure 41(a)(1)(A)(ii). The court formally closed the case on January 9, 2026. This dismissal with prejudice bars Vampire Labs from re-asserting the same claims against Apple on these patents. The terms of the settlement were confidential.
• Stay in District Court: Prior to the dismissal, the district court granted a joint motion to stay all deadlines until January 8, 2026, because the parties had reached a settlement in principle and intended to file dismissal papers.
• IPR Termination: The IPR proceeding (IPR2025-01215) was terminated as "Terminated-Settled". The exact date of the IPR termination due to settlement is not explicitly stated in the provided snippets, but it would have followed the district court settlement. Given the district court settlement on Jan 8, 2026, the IPR would have been terminated shortly thereafter, if not simultaneously.

Now I can structure the response chronologically, addressing all the points requested by the user.

Chronological Order:

1. District Court Filing: Vampire Labs LLC v. Apple Inc., Case No. 1:24-cv-01377 (W.D. Texas), filed on November 12, 2024.
2. IPR Filing: Apple Inc. filed IPR2025-01215 on June 27, 2025.
3. Patent Owner Mandatory Notices (IPR): Vampire Labs filed its Mandatory Notices by July 23, 2025, identifying related district court cases, including 1:24-cv-01377 (WDTX) against Apple.
4. IPR Institution Decision: On December 1, 2025, the PTAB issued an institution decision for IPR2025-01215.
5. District Court Stay: A joint motion to stay all deadlines was granted in the district court case (1:24-cv-01377) because the parties reached a settlement in principle, with dismissal papers expected by January 8, 2026.
6. District Court Dismissal (Settlement): On January 8, 2026, Apple and Vampire Labs filed a joint stipulation of dismissal with prejudice in the district court case, closing it on January 9, 2026.
7. IPR Termination (Settlement): The IPR2025-01215 was terminated as "Terminated-Settled," following the resolution of the parallel district court litigation.The user asked for "key legal developments and outcome." I have identified a parallel district court case, which is a key development, as the IPR was initiated by the defendant in that case, Apple. The settlement of the district court case ultimately led to the termination of the IPR.

I have enough information to fulfill the request.

I will structure the answer by first listing the parallel district court litigation to provide context, and then the IPR developments chronologically.Key Legal Developments and Outcome for IPR2025-01215, Apple Inc. v. Vampire Labs LLC

This case involved an Inter Partes Review (IPR) initiated by Apple Inc. against Vampire Labs LLC concerning U.S. Patent No. 8,358,103, which was ultimately terminated due to a settlement that also resolved a parallel patent infringement lawsuit in district court.

Parallel District Court Litigation

• Filing of Complaint (2024-11-12): Vampire Labs, LLC filed a patent infringement lawsuit against Apple Inc. in the U.S. District Court for the Western District of Texas, Case No. 1:24-cv-01377. The complaint asserted U.S. Patent No. 8,358,103 B2 (along with U.S. Patent No. 8,575,917 B2), both related to inductive wireless charging technology. Judge Alan D. Albright was assigned to the case.

IPR Proceedings at the PTAB

• IPR Petition Filed (2025-06-27): Apple Inc. filed a petition for inter partes review (IPR2025-01215) against Vampire Labs LLC, challenging U.S. Patent No. 8,358,103.
• Patent Owner Mandatory Notices (by 2025-07-23): In response to Apple's petition, Vampire Labs filed its mandatory notices with the PTAB. These notices identified the parallel district court litigation, Vampire Labs, LLC v. Apple Inc. (WDTX, 1:24-cv-01377-ADA), as a related judicial matter.
• Institution Decision (2025-12-01): The Patent Trial and Appeal Board (PTAB) issued a decision to institute the IPR proceeding.

Settlement and Final Disposition

• District Court Motion to Stay (prior to 2026-01-08): The parties in the parallel district court case filed a joint motion to stay all deadlines, informing the court that they had reached a settlement in principle and intended to file dismissal papers on or before January 8, 2026. The court granted this motion.
• District Court Dismissal with Prejudice (2026-01-08): Apple Inc. and Vampire Labs LLC filed a joint stipulation of dismissal with prejudice in the district court case (1:24-cv-01377), pursuant to Federal Rule of Civil Procedure 41(a)(1)(A)(ii). This dismissal prevents Vampire Labs from re-asserting the same patent claims against Apple. The specific terms of the settlement were not publicly disclosed.
• District Court Case Closed (2026-01-09): The U.S. District Court for the Western District of Texas formally closed the infringement case, directing the clerk to terminate all pending motions.
• IPR Termination (Settled): Following the settlement in the parallel district court litigation, IPR2025-01215 was terminated by the PTAB with a status of "Terminated-Settled."

Based on available records for IPR2025-01215, the following attorneys represented Apple Inc. (Petitioner):

Morrison & Foerster LLP

• Alex S. Yap
  • Role: Counsel of Record
  • Firm & Office: Morrison & Foerster LLP, San Francisco, CA.
  • Experience Note: Alex Yap is a partner in Morrison & Foerster's Intellectual Property Group, specializing in patent litigation and inter partes reviews (IPRs) at the PTAB, often representing technology companies like Apple.
• Mehran Arjomand
  • Role: Counsel of Record
  • Firm & Office: Morrison & Foerster LLP, San Francisco, CA.
  • Experience Note: Mehran Arjomand is a partner in the firm's Intellectual Property Group, focusing on patent litigation, post-grant proceedings, and intellectual property counseling, with experience representing petitioners and patent owners in IPRs.
• Bryan A. Blumenkopf
  • Role: Counsel of Record
  • Firm & Office: Morrison & Foerster LLP, San Francisco, CA.
  • Experience Note: Bryan Blumenkopf is an associate in Morrison & Foerster's Intellectual Property Group, concentrating on patent litigation and inter partes review proceedings.

The following attorneys represented Vampire Labs LLC, the patent owner, in IPR2025-01215:

• Gregory S. Donahue

  • Role: Lead Counsel
  • Firm: DiNovo Price LLP, Austin, Texas
  • Experience Note: Mr. Donahue is listed as counsel for Vampire Labs LLC in other patent infringement cases, including Vampire Labs LLC v. Apple Inc. (1:24-CV-01377, W.D. Texas) and Vampire Labs LLC v. Anker Innovations Ltd. (1:24-CV-01378, W.D. Texas), both involving patent 8,358,103.

• Andrew G. DiNovo

  • Role: Back-Up Counsel
  • Firm: DiNovo Price LLP, Austin, Texas
  • Experience Note: Mr. DiNovo also represents Vampire Labs LLC in related district court patent infringement cases.